SCHEMBL2292807

SCHEMBL2292807

CC(=O)O[C@H](C)c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 1/20 0.59
ALDH1A1 P00352 2/20 0.56
CYP3A4 P08684 1/20 0.56
HSD17B10 Q99714 2/20 0.45
TP53 P04637 1/20 0.45
KMT2A Q03164 1/20 0.45
MMP12 P39900 1/20 0.45
TSHR P16473 2/20 0.44
PABPC1 P11940 1/20 0.44
APOBEC3A P31941 1/20 0.44
APOBEC3G Q9HC16 1/20 0.44
FFAR1 O14842 1/20 0.44
RORC P51449 2/20 0.43
CYP2D6 P10635 1/20 0.43
SRC P12931 1/20 0.43
HPGD P15428 1/20 0.42
LPAR1 Q92633 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6267290 1.00 HCAR2 (0.59) HCAR2ALDH1A1CYP3A4HSD17B10TP53
SCHEMBL6392245 1.00 HCAR2 (0.59) HCAR2ALDH1A1CYP3A4HSD17B10TP53
SCHEMBL114793 1.00 HCAR2 (0.59) HCAR2ALDH1A1CYP3A4HSD17B10TP53
Hydrochloric Acid SCHEMBL27545522 0.98 HCAR2 (0.58) HCAR2ALDH1A1CYP3A4HSD17B10TP53
Ethylene Glycol SCHEMBL2515273 0.92 HCAR2 (0.53) HCAR2ALDH1A1CYP3A4HSD17B10TP53
Alcohol SCHEMBL4648871 0.92 HCAR2 (0.53) HCAR2ALDH1A1CYP3A4HSD17B10TP53
Phenyl Ethanol SCHEMBL28893774 0.92 HCAR2 (0.53) HCAR2ALDH1A1CYP3A4HSD17B10TP53
Propionic Acid SCHEMBL15377928 0.91 HCAR2 (0.51) HCAR2ALDH1A1CYP3A4HSD17B10TP53
SCHEMBL10521081 0.88 PTGS2 (0.56) HCAR2ALDH1A1CYP3A4MMP12
SCHEMBL9328620 0.88 PDCD1 (0.51) HCAR2ALDH1A1CYP3A4HSD17B10TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 170 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116807912-A Use of volatile components to limit or eliminate perception of malodor 弗门尼舍有限公司 2023-09-29 CN claimed
CN-122028974-A Ribonucleic acid-based microcapsules 弗门尼舍有限公司 2026-05-12 CN disclosed
US-12616948-B2 Polyamide microcapsules FIRMENICH SA (CH) 2026-05-05 US disclosed
WO-2026087780-A1 CORE-SHELL MICROCAPSULES FIRMENICH SA (CH) 2026-04-30 WO disclosed
US-12606812-B2 Biocatalysts for organic synthesis ENGINZYME AB (CH) 2026-04-21 US disclosed
EP-4711438-A2 PERFUME DELIVERY SYSTEM Firmenich SA (CH) 2026-03-18 EP disclosed
EP-4711037-A2 PERFUME FORMULATION FOR DELIVERY SYSTEM Firmenich SA (CH) 2026-03-18 EP disclosed
EP-4706627-A2 LAUNDRY COMPOSITION Firmenich SA (CH) 2026-03-11 EP disclosed
EP-4077626-B1 LAUNDRY COMPOSITION FIRMENICH & CIE (CH) 2026-02-11 EP disclosed
EP-4077624-B1 PERFUME FORMULATION FOR DELIVERY SYSTEM FIRMENICH & CIE (CH) 2026-02-11 EP disclosed
EP-1483229-A1 RESOLUTION OF CHIRAL COMPOUNDS USING AMINOCYCLOPENTADIENYL RUTHENIUM CATALYSTS Postech Foundation (KR) 2004-12-08 EP disclosed
US-20040219625-A1 Detection method for identifying hydrolases BASF AKTIENGESELLSCHAFT (DE) 2004-11-04 US disclosed
WO-2003076384-A1 RESOLUTION OF CHIRAL COMPOUNDS USING AMINOCYCLOPENTADIENYL RUTHENIUM CATALYSTS POSTECH FOUNDATION (KR) 2003-09-18 WO disclosed
US-5665575-A Microbial esterase for the enantioselective cleavage of 1-phenylethyl acetate BOEHRINGER MANNHEIM GMBH (DE) 1997-09-09 US disclosed
US-5622858-A Arthrobacter strain producing esterase for the enantioselective cleavage of 1-arylalkyl esters BOEHRINGER MANNHEIM GMBH (DE) 1997-04-22 US disclosed
US-5470849-A Anticoagulants SMITHKLINE BEECHAM CORP. (US) 1995-11-28 US disclosed
EP-0557406-A4 -G(G)-TURN PEPTIDOMIMETICS AS FIBRINOGEN ANTAGONISTS 1993-10-06 EP disclosed
EP-0557406-A1 GAMMA-TURN PEPTIDOMIMETICS AS FIBRINOGEN ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1993-09-01 EP disclosed
WO-1992007568-A1 η-TURN PEPTIDOMIMETICS AS FIBRINOGEN ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1992-05-14 WO disclosed
US-4525309-A Lewis acid catalysis of the homologation of boronic esters with haloalkylmetal reagents WASHINGTON STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 1985-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12606812-B2 Biocatalysts for organic synthesis CTSS, CTSD, CTSV HCAR2 4289/4885ALDH1A1 2812/4885CYP3A4 695/4885
US-12616948-B2 Polyamide microcapsules HDHD5, DDC, USP39 HCAR2 1332/4885ALDH1A1 4007/4885CYP3A4 4664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.